Sweetener tagatose may tame blood sugar and feed good gut bugs

NCT ID NCT06920641

First seen Apr 21, 2026 · Last updated Jun 21, 2026 · Updated 10 times

Summary

This study tested whether tagatose, a low-calorie sweetener, can act as a prebiotic—meaning it selectively feeds beneficial gut bacteria and improves blood sugar control. Fifty-nine healthy adults with slightly high blood sugar or insulin resistance took either tagatose or a placebo (sucrose) daily for four weeks, then switched after a break. Researchers measured blood sugar responses and gut bacteria changes to see if tagatose offers a health benefit beyond just sweetening.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MICROBIAL COLONIZATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • INQUIS Clinical Research

    Toronto, Ontario, M5C 2N8, Canada

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

tagatose

What this could lead to

If tagatose is shown to be a prebiotic, it could point toward a sugar substitute that also supports healthy blood sugar and gut bacteria.

What could go wrong

This is a small, early-stage study in healthy adults, not people with diabetes. The results may not apply to the general population, and tagatose may not prove effective.

Conditions

The condition(s) this trial relates to.

glucose intolerance infectious disease Insulin Resistance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.